Health Technology Assessment (HTA) agencies usually rely on randomised controlled trials for clinical data when evaluating drugs, but these do not always tell the entire story. Both biopharmaceutical companies and HTA agencies have been considering real world evidence (RWE) as a complementary source of data, but to what extent is it actually used and is it worth the attention? Read more here. (Source: pharmaphorum, 1/27/15)
You are here: / / How Much Does Real World Evidence Really Matter In Health Technology Assessments?